About Vidyasagar Vuligonda
Form D filings for Io Therapeutics in 2023 list Vidyasagar Vuligonda as executive officer.
Vidyasagar Vuligonda first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Vidyasagar Vuligonda in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Vidyasagar Vuligonda works with at each company, as listed on that company's latest Form D.
Io Therapeutics, Inc. · Form D/A, Aug 3, 2023